These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17383993)

  • 21. Short-term complications of intravitreal injections of triamcinolone and bevacizumab.
    Jonas JB; Spandau UH; Schlichtenbrede F
    Eye (Lond); 2008 Apr; 22(4):590-1. PubMed ID: 18292795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of intravitreal triamcinolone in uveitis.
    Kok H; Lau C; Maycock N; McCluskey P; Lightman S
    Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of selective laser trabeculoplasty on intraocular pressure in patients with intravitreal steroid-induced elevated intraocular pressure.
    Rubin B; Taglienti A; Rothman RF; Marcus CH; Serle JB
    J Glaucoma; 2008; 17(4):287-92. PubMed ID: 18552614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Steroid hypopyon following intravitreal triamcinolone acetonide injection in a pseudophakic patient.
    Amato JE; Lee DH; Santos BA; Akduman L
    Ocul Immunol Inflamm; 2005; 13(2-3):245-7. PubMed ID: 16019686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intravitreal triamcinolone acetonide Complication of infectious and sterile endophthalmitis].
    Kreissig I; Degenring RF; Jonas JB
    Ophthalmologe; 2006 Jan; 103(1):30-4. PubMed ID: 15915332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravitreal triamcinolone acetonide and intraocular pressure.
    Smithen LM; Ober MD; Maranan L; Spaide RF
    Am J Ophthalmol; 2004 Nov; 138(5):740-3. PubMed ID: 15531307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
    Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
    Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of intravitreal triamcinolone acetonide in the treatment of experimental Staphylococcus epidermidis endophthalmitis.
    Hosseini H; Mehryar M; Eghtedari M; Ahmadi F; Nowroozizadeh S
    Curr Eye Res; 2009 Feb; 34(2):145-51. PubMed ID: 19219686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sterile endophthalmitis after intravitreal triamcinolone: a possible association with uveitis.
    Taban M; Singh RP; Chung JY; Lowder CY; Perez VL; Kaiser PK
    Am J Ophthalmol; 2007 Jul; 144(1):50-54. PubMed ID: 17601427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endophthalmitis with retinal necrosis following intravitreal triamcinolone acetonide injection.
    Aggermann T; Stolba U; Brunner S; Binder S
    Ophthalmologica; 2006; 220(2):131-3. PubMed ID: 16491037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
    Jonas JB; Kreissig I; Degenring RF
    Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refractory severe ocular hypertension after intravitreal triamcinolone acetonide injection.
    Yang CS; Chen MJ; Chou CK; Hsu WM
    Ophthalmologica; 2005; 219(6):413-5. PubMed ID: 16286805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Survey of triamcinolone-related non-infectious endophthalmitis].
    Sakamoto T; Ishibashi T; Ogura Y; Shiraga F; Takeuchi S; Yamashita H;
    Nippon Ganka Gakkai Zasshi; 2011 Jun; 115(6):523-8. PubMed ID: 21735756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presumed sterile endophthalmitis following intravitreal triamcinolone acetonide injection.
    Moshfeghi DM; Kaiser PK; Bakri SJ; Kaiser RS; Maturi RK; Sears JE; Scott IU; Belmont J; Beer PM; Quiroz-Mercado H; Mieler WF
    Ophthalmic Surg Lasers Imaging; 2005; 36(1):24-9. PubMed ID: 15688968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.
    Jonas JB; Kreissig I; Degenring R
    Prog Retin Eye Res; 2005 Sep; 24(5):587-611. PubMed ID: 16005407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravitreal triamcinolone will cause posterior subcapsular cataract in most eyes with diabetic maculopathy within 2 years.
    Islam MS; Vernon SA; Negi A
    Eye (Lond); 2007 Mar; 21(3):321-3. PubMed ID: 16543927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presumed Sterile Endophthalmitis Afer Intravitreal Triamcinolone (Kenalog)-More Common and Less Benign Than We Thought?
    Fong AH; Chan CK
    Asia Pac J Ophthalmol (Phila); 2017; 6(1):45-49. PubMed ID: 28161929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal triamcinolone acetonide: a change in a paradigm.
    Jonas JB
    Ophthalmic Res; 2006; 38(4):218-45. PubMed ID: 16763379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
    Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
    Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Jonas JB; Degenring RF; Kreissig I; Akkoyun I; Kamppeter BA
    Ophthalmology; 2005 Apr; 112(4):593-8. PubMed ID: 15808249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.